English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Mallinckrodt Plc
Press release submission
| Sep 24, 2019
MALLINCKRODT: Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of StrataGraft® Regenerative Tissue in Patients with Deep Partial-thickness Thermal Burns
Trending
+
Pharmaceuticals
Patient Daily
| Oct 27, 2024
James Tracy named new president of ACAAI
+
Pharmaceuticals
Patient Daily
| Oct 29, 2024
Fight For Air Climb returns to Orlando in March
+
Pharmaceuticals
Patient Daily
| Oct 31, 2024
American Lung Association promotes actions during Lung Cancer Awareness Month
+
Pharmaceuticals
Patient Daily
| Oct 30, 2024
Healthcare open enrollment begins November 1 with new eligibility expansions
